Home
/

Supplements That Increase Estrogen Naturally

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 31, 2026
Last updated
May 30, 2026
Key takeaway:

"Estrogen-boosting" supplements mostly don't raise circulating estradiol — phytoestrogens bind estrogen receptors selectively rather than replacing estrogen. A 2025 meta-analysis of 40 RCTs found soy isoflavones did not significantly alter serum estradiol or FSH in postmenopausal women. Testing estradiol and FSH before and during use is the only way to know whether any compound is actually shifting your hormonal balance.

Read more →
Table of contents

What Phytoestrogens and Herbal Supplements Actually Do

The term "estrogen-boosting supplement" is misleading. Most supplements marketed for hormonal support don't increase circulating estrogen levels the way hormone replacement therapy does. Instead, they contain plant compounds called phytoestrogens or herbs that interact with estrogen receptors in the body, sometimes activating them weakly, sometimes blocking stronger estrogens, and sometimes doing neither.

Phytoestrogens: Soy isoflavones and red clover

Phytoestrogens are plant-derived compounds with a chemical structure similar enough to estradiol that they can bind to estrogen receptors. The most studied are isoflavones, found in soy (genistein and daidzein) and red clover (biochanin A and formononetin). These compounds act as selective estrogen receptor modulators, they may activate estrogen receptors in some tissues (like bone) while blocking them in others (like breast tissue). A 2025 meta-analysis of 40 randomized controlled trials (n=3,285) found that soy isoflavones did not significantly alter serum estradiol, FSH, or other measures of estrogenicity in postmenopausal women, despite reducing hot flash frequency in some trials.

Black cohosh: Receptor modulation without estrogen

Black cohosh (Cimicifuga racemosa) is widely used in Europe for menopausal symptoms, but its mechanism remains unclear. Early research suggested it might bind to estrogen receptors, but more recent studies suggest it may work through serotonin pathways and other non-estrogenic mechanisms, though its exact mechanism remains incompletely characterized. It does not raise estradiol levels and should not be considered an herbal estrogen replacement.

Dong quai: Traditional use, limited evidence

Dong quai (Angelica sinensis) is a staple of traditional Chinese medicine for menstrual and menopausal concerns. However, a double-blind, placebo-controlled trial found it had no estrogenic effect and no impact on postmenopausal symptoms when used alone. It's often combined with other herbs in formulas, making it difficult to assess its independent contribution.

Vitex (Chasteberry): Pituitary modulation

Vitex agnus-castus works on the pituitary gland to influence the release of luteinizing hormone and prolactin, which indirectly affects progesterone and estrogen balance. It's more commonly used for premenstrual syndrome and menstrual irregularities than for menopause, and it doesn't directly increase estrogen levels.

How Estrogen-Supporting Supplements Affect the Body

Understanding what these supplements do, and don't do, requires distinguishing between raising hormone levels and modulating receptor activity.

Effects on estrogen receptors

Phytoestrogens bind to estrogen receptors alpha and beta with varying affinity. Genistein, for example, binds more strongly to estrogen receptor beta, which is more prevalent in bone, cardiovascular tissue, and the brain. This selective binding explains why soy isoflavones may support bone density without significantly affecting breast or uterine tissue. The effect is much weaker than endogenous estradiol, phytoestrogens are estimated to be 100 to 10,000 times less potent depending on the compound and receptor subtype.

Effects on the hypothalamic-pituitary-ovarian axis

In perimenopause and menopause, declining ovarian function leads to low estradiol and elevated FSH as the pituitary tries to stimulate the ovaries. Phytoestrogen supplementation does not suppress FSH or restore estradiol to premenopausal levels. This is why blood tests after supplementation typically show no change in hormone levels, even when symptoms improve.

Effects on bone and cardiovascular health

Estrogen receptor beta activation in bone tissue may slow bone resorption, which is why some studies show modest improvements in bone density markers with long-term soy isoflavone use. Similarly, phytoestrogens may improve endothelial function and lipid profiles through receptor-mediated pathways, though the clinical significance remains debated.

Effects on neurotransmitter pathways

Black cohosh, kudzu, and licorice root may influence serotonin and GABA pathways, which could explain their effects on mood and hot flashes independent of estrogen receptor binding. This is a reminder that "estrogen-supporting" supplements often work through multiple mechanisms, not just hormonal ones.

What the Clinical Evidence Actually Shows

The research on estrogen-supporting supplements is mixed, with study quality and formulation variability complicating interpretation.

Soy isoflavones

A 2015 meta-analysis found that phytoestrogens, including soy isoflavones, were associated with a modest but statistically significant reduction in hot flash frequency in menopausal women without serious side effects. A separate 2013 Cochrane review of 43 trials found no conclusive evidence overall, though genistein concentrates showed promise. A 2025 systematic review confirmed that soy isoflavones do not alter serum estradiol, FSH, or sex hormone-binding globulin, meaning they don't function as hormone replacement.

Red clover

Red clover isoflavones have been studied for cardiovascular and menopausal symptoms. A 2022 trial found that short-term supplementation reduced vascular inflammation in early postmenopausal women, but evidence for symptom relief is inconsistent. Some trials show benefit, others show none, likely due to differences in isoflavone content and individual metabolism.

Black cohosh

Multiple trials support black cohosh for reducing hot flashes and improving quality of life in menopausal women, though the mechanism is not estrogenic. The 2008 HALT trial found that it does not increase endometrial thickness or alter hormone levels, making it a reasonable option for women who cannot or prefer not to use hormone therapy.

Dong quai

Clinical evidence for dong quai as a standalone supplement is weak. A 1997 study published in Fertility and Sterility found it no more effective than placebo for menopausal symptoms. It may have value in combination formulas, but more research is needed.

Vitex

Meta-analyses from 2017 and 2019 support vitex's effectiveness for premenstrual syndrome, but its role in menopause is less clear. It may help women in perimenopause with irregular cycles, but it's not a primary option for postmenopausal symptom management.

Dosing, Timing, and Supplement Form

Soy isoflavones

Studied doses range from 40 to 80 mg of isoflavones per day, typically divided into two doses. Supplements standardized to genistein and daidzein content are more reliable than generic soy extracts. Absorption improves when taken with food, and effects may take 4 to 12 weeks to become noticeable.

Red clover

Clinical trials have used 40 to 80 mg of isoflavones daily, often standardized to biochanin A and formononetin. Like soy, red clover is best taken with meals, and benefits emerge gradually over weeks to months.

Black cohosh

The most commonly studied dose is 40 to 80 mg of a standardized extract per day, typically taken in divided doses. Quality matters, look for products standardized to triterpene glycosides. Black cohosh is generally taken for at least 8 weeks before assessing effectiveness.

Dong quai

Traditional doses range from 3 to 15 grams of dried root per day, often prepared as a tea or tincture. Standardized extracts are less common, and evidence for optimal dosing is limited.

Vitex

Typical doses are 20 to 40 mg of dried fruit extract per day, taken in the morning. Vitex works best when used consistently over several menstrual cycles.

Who Should Use Caution, and Why

Estrogen-supporting supplements are not universally safe, and certain populations should avoid them or use them only under medical supervision.

  • Women with a history of hormone-sensitive cancers (breast, ovarian, endometrial) should avoid phytoestrogens and herbal estrogen modulators, as even weak receptor activation could theoretically stimulate residual cancer cells.
  • Women taking tamoxifen or aromatase inhibitors should not use phytoestrogens, as they may interfere with cancer treatment by competing for estrogen receptors.
  • Women with a history of blood clots, stroke, or cardiovascular disease should consult a physician before using supplements that affect vascular function, including red clover and soy isoflavones.
  • Women with liver disease should avoid black cohosh, as rare cases of hepatotoxicity have been reported, though causality is debated.
  • Women on thyroid medication should monitor thyroid function if using soy isoflavones, as soy may interfere with levothyroxine absorption, though evidence is mixed.
  • Women with endometriosis or uterine fibroids should use phytoestrogens cautiously, as estrogen receptor activation could theoretically worsen symptoms, though clinical evidence is limited.

Individual variation in response

Gut microbiome composition affects how phytoestrogens are metabolized. Some people produce equol, a metabolite of daidzein with stronger estrogenic activity, while others don't. Equol producers may experience more benefit from soy isoflavones, but testing for equol production is not widely available.

Connecting Supplements to Biomarkers

If you're considering estrogen-supporting supplements, knowing your baseline hormone levels helps clarify whether supplementation makes sense, and whether it's working.

  • Estradiol: The primary form of estrogen in premenopausal women. Low levels in perimenopause or menopause confirm declining ovarian function. Phytoestrogens won't raise this number, but tracking it over time shows whether you're in menopause or still cycling.
  • FSH: Elevated FSH (typically above 30 to 40 IU/L) indicates reduced ovarian reserve and is a marker of menopause. Supplements won't lower FSH, but knowing your level helps confirm your hormonal stage.
  • LH: Like FSH, LH rises in menopause. It's less commonly tested but provides additional context for ovarian function.
  • SHBG: Sex hormone-binding globulin binds estrogen and testosterone, affecting how much is biologically active. Phytoestrogens don't typically alter SHBG, but tracking it helps interpret total versus free hormone levels.
  • TSH: Thyroid function can mimic or worsen menopausal symptoms. If you're using soy supplements, monitor TSH to ensure they're not interfering with thyroid medication absorption.

Testing before starting supplementation establishes a baseline. Retesting after 3 to 6 months shows whether your hormone levels have changed (they likely won't with phytoestrogens) and whether symptoms have improved independent of lab values.

How Superpower Helps You Make Smarter Supplement Decisions

If you're considering supplements to support estrogen levels, Superpower's 100+ biomarker panel includes the hormonal markers that show where you are in the menopausal transition, so you're making decisions based on data, not guesswork. Knowing your estradiol, FSH, and thyroid function before you start supplementing helps you track whether symptoms improve and whether your approach needs adjustment. Supplements don't replace declining hormones, but understanding your baseline makes it easier to evaluate whether they're worth continuing.

FAQs

No. Phytoestrogens like soy isoflavones and red clover bind to estrogen receptors but do not increase circulating estradiol levels. They act as weak receptor modulators, not hormone replacements. Clinical trials consistently show no change in serum estradiol or FSH with phytoestrogen supplementation.

Black cohosh does not appear to have estrogenic activity and has been studied in breast cancer survivors without clear evidence of harm. However, in vitro data suggest it may inhibit CYP2D6, which could affect tamoxifen metabolism. You should discuss any supplement use with your oncologist, especially if you're on tamoxifen or aromatase inhibitors.

Most studies show that symptom improvement, if it occurs, takes 4 to 12 weeks of consistent use. Phytoestrogens and herbal supplements work gradually, not immediately. If you see no benefit after 3 months, the supplement may not be effective for you.

Long-term studies (up to 3 years) show that soy isoflavones are generally safe for healthy postmenopausal women, with no increase in endometrial thickness or breast density. However, women with hormone-sensitive conditions should avoid them, and anyone using them long-term should monitor thyroid function if on thyroid medication.

Combining supplements increases the risk of interactions and side effects without clear evidence of added benefit. If you're using more than one, work with a healthcare provider to monitor for adverse effects, especially if you're on medications that affect hormones, blood clotting, or liver function.

Some evidence suggests that soy isoflavones may modestly slow bone loss in postmenopausal women, likely through estrogen receptor beta activation in bone tissue. However, the effect is smaller than that of prescription osteoporosis medications or hormone therapy. If bone health is your primary concern, discuss more effective options with your doctor.

References

  1. Viscardi, G., Back, S., Ahmed, A., Yang, S., Mejia, S. B., Zurbau, A., Khan, T. A., Selk, A., Messina, M., Kendall, C. W., Jenkins, D. J., Sievenpiper, J. L., & Chiavaroli, L. (2025). Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Advances in nutrition (Bethesda, Md.), 16(1), 100327. https://doi.org/10.1016/j.advnut.2024.100327
  2. Ruhlen, R. L., Sun, G. Y., & Sauter, E. R. (2008). Black Cohosh: Insights into its Mechanism(s) of Action. Integrative medicine insights, 3, 21-32. https://pubmed.ncbi.nlm.nih.gov/21614156/
  3. Hirata, J. D., Swiersz, L. M., Zell, B., Small, R., & Ettinger, B. (1997). Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertility and sterility, 68(6), 981-6. https://doi.org/10.1016/s0015-0282(97)00397-x
  4. Manas, E. S., Xu, Z. B., Unwalla, R. J., & Somers, W. S. (2004). Understanding the selectivity of genistein for human estrogen receptor-beta using X-ray crystallography and computational methods. Structure (London, England : 1993), 12(12), 2197-207. https://doi.org/10.1016/j.str.2004.09.015
  5. Patisaul, H. B., & Jefferson, W. (2010). The pros and cons of phytoestrogens. Frontiers in neuroendocrinology, 31(4), 400-19. https://doi.org/10.1016/j.yfrne.2010.03.003
  6. Barańska, A., Kanadys, W., Bogdan, M., Stępień, E., Barczyński, B., Kłak, A., Augustynowicz, A., Szajnik, M., & Religioni, U. (2022). The Role of Soy Isoflavones in the Prevention of Bone Loss in Postmenopausal Women: A Systematic Review with Meta-Analysis of Randomized Controlled Trials. Journal of clinical medicine, 11(16). https://doi.org/10.3390/jcm11164676
  7. Hajirahimkhan, A., Dietz, B. M., & Bolton, J. L. (2013). Botanical modulation of menopausal symptoms: mechanisms of action?. Planta medica, 79(7), 538-53. https://doi.org/10.1055/s-0032-1328187
  8. Chen, M. N., Lin, C. C., & Liu, C. F. (2015). Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review. Climacteric : the journal of the International Menopause Society, 18(2), 260-9. https://doi.org/10.3109/13697137.2014.966241
  9. Lethaby, A., Marjoribanks, J., Kronenberg, F., Roberts, H., Eden, J., & Brown, J. (2013). Phytoestrogens for menopausal vasomotor symptoms. The Cochrane database of systematic reviews, 2013(12), CD001395. https://doi.org/10.1002/14651858.CD001395.pub4
  10. Wickham, K. A., Nørregaard, L. B., Oxfeldt, M., Cheung, S. S., Gliemann, L., Hansen, M., & Hellsten, Y. (2022). Short-Term Supplementation With Fermented Red Clover Extract Reduces Vascular Inflammation in Early Post-menopausal Women. Frontiers in cardiovascular medicine, 9, 826959. https://doi.org/10.3389/fcvm.2022.826959
  11. Reed, S. D., Newton, K. M., LaCroix, A. Z., Grothaus, L. C., Grieco, V. S., & Ehrlich, K. (2008). Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Menopause (New York, N.Y.), 15(1), 51-8. https://pubmed.ncbi.nlm.nih.gov/18257142/
  12. Verkaik, S., Kamperman, A. M., van Westrhenen, R., & Schulte, P. F. J. (2017). The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis. American journal of obstetrics and gynecology, 217(2), 150-166. https://doi.org/10.1016/j.ajog.2017.02.028
  13. Csupor, D., Lantos, T., Hegyi, P., Benkő, R., Viola, R., Gyöngyi, Z., Csécsei, P., Tóth, B., Vasas, A., Márta, K., Rostás, I., Szentesi, A., & Matuz, M. (2019). Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomised controlled trials. Complementary therapies in medicine, 47, 102190. https://doi.org/10.1016/j.ctim.2019.08.024
  14. Muqeet Adnan, M., Khan, M., Hashmi, S., Hamza, M., AbdulMujeeb, S., & Amer, S. (2014). Black cohosh and liver toxicity: is there a relationship?. Case reports in gastrointestinal medicine, 2014, 860614. https://doi.org/10.1155/2014/860614
  15. Gatta, E., Maltese, V., Cavadini, M., Anelli, V., Bambini, F., Buoso, C., Facondo, P., Pirola, I., Delbarba, A., & Cappelli, C. (2023). Interference or Noninterference Between Soy and Levothyroxine: That Is the Question. A Narrative Review of Literature. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 29(11), 897-901. https://doi.org/10.1016/j.eprac.2023.08.009
  16. Iino, C., Shimoyama, T., Iino, K., Yokoyama, Y., Chinda, D., Sakuraba, H., Fukuda, S., & Nakaji, S. (2019). Daidzein Intake Is Associated with Equol Producing Status through an Increase in the Intestinal Bacteria Responsible for Equol Production. Nutrients, 11(2). https://doi.org/10.3390/nu11020433
  17. Rostock, M., Fischer, J., Mumm, A., Stammwitz, U., Saller, R., & Bartsch, H. H. (2011). Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 27(10), 844-8. https://doi.org/10.3109/09513590.2010.538097
  18. Li, J., Gödecke, T., Chen, S. N., Imai, A., Lankin, D. C., Farnsworth, N. R., Pauli, G. F., van Breemen, R. B., & Nikolić, D. (2011). In vitro metabolic interactions between black cohosh (Cimicifuga racemosa) and tamoxifen via inhibition of cytochromes P450 2D6 and 3A4. Xenobiotica; the fate of foreign compounds in biological systems. https://doi.org/10.3109/00498254.2011.603385
  19. Alekel, D. L., Genschel, U., Koehler, K. J., Hofmann, H., Van Loan, M. D., Beer, B. S., Hanson, L. N., Peterson, C. T., & Kurzer, M. S. (2015). Soy Isoflavones for Reducing Bone Loss Study: effects of a 3-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women. Menopause (New York, N.Y.), 22(2), 185-97. https://doi.org/10.1097/GME.0000000000000280
  20. Wei, P., Liu, M., Chen, Y., & Chen, D. C. (2012). Systematic review of soy isoflavone supplements on osteoporosis in women. Asian Pacific journal of tropical medicine, 5(3), 243-8. https://doi.org/10.1016/S1995-7645(12)60033-9

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey